Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
Clinical Trial Listings
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
»
CenterWatch Staff
Articles by CenterWatch Staff
Arena posts phase I trial results
July 13, 2011
CenterWatch Staff
Ignite Health names Lefkowitz chief creative officer
July 13, 2011
CenterWatch Staff
Delta Point names Murphy executive account director
July 13, 2011
CenterWatch Staff
BD Biosciences names research grant recipients
July 13, 2011
CenterWatch Staff
ADDF, Charles River collaborate in research award program
July 13, 2011
CenterWatch Staff
INC Research completes acquisition of Kendle International
July 13, 2011
CenterWatch Staff
Gilead to allow generic AIDS drugs through Medicines Patent Pool
July 13, 2011
CenterWatch Staff
FDA proposes targeted drug testing guidelines
July 13, 2011
CenterWatch Staff
Micromet collaborates with Amgen
July 12, 2011
CenterWatch Staff
Avila names Hirsch CFO
July 12, 2011
CenterWatch Staff
Previous
1
2
…
985
986
987
988
989
990
991
992
993
…
1165
1166
Next
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here